Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Child-Pugh Score”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Early research (Phase 1)Study completedNCT01600976
What this trial is testing

Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Janssen Infectious Diseases BVBA 24
Early research (Phase 1)Ended earlyNCT04322253
What this trial is testing

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose in Participants With Liver Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Pharmacology, Clinical
Bayer 22
Large-scale testing (Phase 3)Study completedNCT02219503
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie 60
Large-scale testing (Phase 3)Study completedNCT02201901
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 268
Early research (Phase 1)Study completedNCT05661344
What this trial is testing

Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 28
Early research (Phase 1)Study completedNCT01111318
What this trial is testing

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Who this might be right for
Hepatic InsufficiencyHealthy
Boehringer Ingelheim 36
Large-scale testing (Phase 3)Study completedNCT02115321
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 40
Testing effectiveness (Phase 2)UnknownNCT04454762
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function

Who this might be right for
Hepatocellular Carcinoma
Johannes Gutenberg University Mainz 20
Testing effectiveness (Phase 2)UnknownNCT05009680
What this trial is testing

A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Galecto Biotech AB 54
Large-scale testing (Phase 3)Looking for participantsNCT05201404
What this trial is testing

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma 471
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Early research (Phase 1)Study completedNCT06402721
What this trial is testing

Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Chronic Kidney DiseaseHepatic Impairment
Bayer 24
Testing effectiveness (Phase 2)Study completedNCT01188733
What this trial is testing

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionEsophageal Varices
Mayo Clinic 39
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT03846843
What this trial is testing

OCR002-SP103 - Oral Immediate Release Study

Who this might be right for
Cirrhosis
Ocera Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT05731908
What this trial is testing

Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 28
Large-scale testing (Phase 3)Study completedNCT02219477
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

Who this might be right for
Chronic Hepatitis CDecompensated CirrhosisHepatitis C Virus
AbbVie 36
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Early research (Phase 1)Study completedNCT04993157
What this trial is testing

Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 54
Load More Results